ÂÜÀòÂÒÂ×

Carine Bossard is a seasoned professional in the field of tumor biology, currently serving as Senior Director at Biosplice Therapeutics since November 2020, where responsibilities include the development of novel therapeutics that target alternative pre-mRNA splicing. Prior experience includes positions at Samumed, LLC, where Carine progressed from Scientist I to Manager, focusing on small molecule Wnt pathway modulators for various medical applications, and a postdoctoral role at the Salk Institute, emphasizing oncolytic adenoviral therapies. Educational credentials include a PhD in Molecular and Cell Biology from Université Paul Sabatier Toulouse III and an Engineer degree from INSA Toulouse, complemented by a certificate from the Biocom Institute.